FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new 1-azabicycloalkyl derivatives of formula (I): 
wherein A represents O or N(R1); Y represents a group of formulas: 
or 
R represents substituted or unsubstituted phenyl or indolylradical, to their use as pharmaceutical agents, to pharmaceutical compositions containing them, to methods of treating and preventing mental and neurodegenerative diseases.
EFFECT: preparing pharmaceutical agents for treating and preventing mental and neurodegenerative diseases.
17 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-(HETEROARYLOXY)-2-ALKYL-1-AZABICYCLOALKYL DERIVATIVES AS LIGANDS OF ALPHA-7-nAChR (NICOTINIC ACETYLCHOLINE RECEPTORS), MEANT FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES | 2005 |
|
RU2402551C2 |
| AZABICYCLOALKYL ETHERS AND THEIR APPLICATION AS ALPHA7-nAChR AGONISTS | 2003 |
|
RU2352569C2 |
| (1-AZABICYCLO[3,3,1]NON-4-YL)-[5-(1H-INDOL-5-YL)-HETEROARYL]-AMINES AS CHOLINERGIC LIGANDS nChAR FOR TREATING PSYCHOTIC AND NEURODEGENERATIVE DISORDERS | 2006 |
|
RU2440350C2 |
| [(1H-INDOL-5-YL)-HETEROARYLOXY]-1-AZABICYCLO[3,3,1]NONANES AS CHOLINERGIC LIGANDS N-ACHR, APPLICABLE FOR PSYCHOTIC AND NEURODEGENERATIVE DISORDERS | 2006 |
|
RU2471797C2 |
| AZABICYCLIC ALKANE DERIVATIVES SUBSTITUTED WITH CONDENSED BICYCLOHETEROCYCLE | 2007 |
|
RU2437884C2 |
| BRIDGED N-CYCLYC SULPHONAMIDO-INHIBITORS OF GAMMA-SECRETASE | 2006 |
|
RU2422443C2 |
| LIGANDS OF NICOTINE RECEPTOR α, THEIR OBTAINING AND APPLICATION | 2005 |
|
RU2418797C2 |
| RECEPTOR SUBTYPE-SELECTIVE AZABICYCLOALKANE DERIVATIVES | 2008 |
|
RU2417984C1 |
| MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS | 2019 |
|
RU2778294C2 |
| POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | 2017 |
|
RU2750935C2 |
